Molnupiravir N-1 CAS 2346620-55-9 COVID-19 Boleng bo Phahameng
Phepelo ea Khoebo ea Molnupiravir le Litšehare tse Amanang le Boleng bo Phahameng
Uridine CAS 58-96-8
Cytidine CAS 65-46-3
Molnupiravir N-1 CAS 2346620-55-9
Molnupiravir (EIDD-2801) CAS 2349386-89-4
| Lebitso la Lik'hemik'hale | Molnupiravir N-1 |
| Litlhaloso tse tšoanang | ((3aR,4R,6R,6aR)-6-(E)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3, 4-d][1,3]dioxol-4-yl)methyl isobutyrate;Molnupiravir Ea Mahareng;Molnupiravir Dimethyl Dioxol Ho se hloeke;Tšilafalo ea Molnupiravir 11 |
| Nomoro ea CAS | 2346620-55-9 |
| Nomoro ea KAtse | RF-PI310 |
| Boemo ba Setoko | Ka Setokong, Phatlalatso e Eketsehile ho fihla ho Makholo a Lik'hilograma |
| Foromo ea limolek'hule | C16H23N3O7 |
| Boima ba Molek'hule | 369.37 |
| Solubility | E qhibiliha ka DMSO |
| Botenya | 1.51±0.1 g/cm3 |
| Mocheso oa ho Romela | Ambient |
| Brand | Ruifu Chemical |
| Ntho | Litlhaloso |
| Ponahalo | Phofo e tšoeu ho isa ho e tšoeu |
| Tahlehelo ka ho Omisa | ≤1.0% |
| Masalla a ho Ignition | ≤0.20% |
| Tšilafalo e le Mong | ≤0.50% |
| Litšila ka Kakaretso | ≤2.0% |
| Litšepe tse boima | ≤20ppm |
| Bohloeki | ≥98.0% |
| Tekanyetso ea Teko | Maemo a Khoebo |
| Tšebeliso | Hare ha Molnupiravir (CAS 2349386-89-4) COVID-19 |
Sephutheloana: Botlolo, Aluminium foil bag, Cardboard drum, 25kg/Drum, kapa ho latela tlhoko ea moreki.
Boemo ba polokelo:Boloka ka lijaneng tse koetsoeng sebakeng se phodileng le se omileng;Sireletsa khanya, mongobo le ho hlaseloa ke likokoanyana.
Molnupiravir N-1 (CAS 2346620-55-9), ke setsi sa mahareng sa Molnupiravir (CAS 2349386-89-4) kalafong ea COVID-19.Molnupiravir (EIDD-2801) ke mofuta o fumanehang ka molomo oa analog e matla haholo ea ribonucleoside e thibelang ho ikatisa ha livaerase tse ngata tsa RNA ho kenyeletsoa SARS-CoV-2, sesosa sa COVID-19.EIDD-2801 (7 mg/kg; po; habeli ka letsatsi bakeng sa matsatsi a 3.5) e fokotsa haholo moroalo oa kokoana-hloko e tšolotsoeng le nako ea feberu.Molnupiravir (EIDD-2801) e sebelisoa hantle ka har'a vivo ka mor'a ho monngoa, e leng se etsang hore ho fumanoe NHC ea mahala feela plasma.EIDD-2801 e fokotsa ka matla li-titers tse tšoaetsanoang tsa MERS-CoV, likokoana-hloko tsa RNA, le pathogenesis tlas'a maemo a mabeli a prophylactic le a pele a phekolo.Molnupiravir (EIDD-2801, MK-4482) ke prodrug ea molomo ea bioavailable ea ribonucleoside analog β-d-N4-hydroxycytidine (NHC; EIDD-1931) e nang le ts'ebetso e pharaletseng ea antiviral khahlanong le SARS-CoV-2, MERS-CoV, SARS-CoV, le moemeli ea bakang COVID-19.
